With clinics across the UK, eXroid® has established itself as a leader in non-invasive haemorrhoid treatment, earning a strong reputation for pioneering care for what for many is an embarrassing condition. As demand for their innovative electrotherapy surged, eXroid® recognised the need to give more patients the opportunity to receive the treatment they needed by introducing flexible payment options.
The Challenge
NHS funding cuts in treatments of the condition, has created a sharp rise in the number of people seeking private care to treat haemorrhoids. Many patients faced a difficult choice: delay a treatment at no cost and continue to suffer, or opt for private healthcare treatment and should the financial cost upfront. To make the decision easier and in order to get more patients treated quickly, eXroid® decided to offer a patient payment solution that made the process of funding the treatment more flexible and manageable for patients.
The Solution
eXroid® launched an interest-free finance solution, giving patients the option to spread the cost of treatment into manageable monthly instalments. This new approach eliminated the financial barriers that once stood in the way of many, ensuring that more patients can now access their innovative, non-invasive procedure. With this flexible plan, eXroid® now offers a practical, affordable path to life-changing treatment, making healthcare choices easier for all.
The Result
Since introducing the interest-free finance option, eXroid® has experienced a notable surge in patient treatment . Patients, reassured by the ability to spread out costs interest-free, now approach treatment with renewed confidence. This shift has not only increased acceptance rates but has also boosted patient satisfaction, as individuals feel empowered to make informed, stress-free healthcare decisions. By offering flexible payment options, eXroid® has made top-tier treatment more accessible, providing patients with both financial relief and the freedom to take control of their health.
“Partnering with Snowbird Finance has made offering flexible payment options easy and stress-free for eXroid and our patients. The onboarding process was seamless, and their team provided outstanding customer service throughout. Highly recommend Snowbird Finance for clinics looking to simplify treatment finance” – Lisa Ellerker, Finance and Commercial Director, eXroid®
The introduction of interest-free finance has transformed haemorrhoid treatment accessibility, driving higher patient uptake and confidence through flexible payment options. By removing financial barriers, eXroid® has enabled more of the 10 million UK residents that are suffering with haemorrhoids each year to find relief and comfort quicker and easier.